Navigation Links
Takeda Announces PDUFA Action Date for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
Date:11/1/2011

DEERFIELD, Ill., Nov. 1, 2011 /PRNewswire/ -- Takeda Global Research & Development Center, Inc., (Takeda) announced that the U.S. Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) action date of January 25, 2012 for the review of its investigational type 2 diabetes therapy alogliptin, and the fixed-dose combination therapy alogliptin/pioglitazone, which combines alogliptin with pioglitazone in a single tablet.  

Currently, the FDA is reviewing the new drug applications (NDA) for the investigational therapies, which were resubmitted on July 25, 2011; the FDA has categorized these as Class 2 responses, requiring up to six months for review. Alogliptin is a selective dipeptidyl peptidase IV inhibitor (DPP-4i) under investigation in the United States (U.S.) for the treatment of type 2 diabetes as an adjunct to diet and exercise. Discovered by Takeda San Diego, Inc., alogliptin is designed to slow the inactivation of incretin hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide), which play a role in regulating blood glucose levels. Pioglitazone was approved in 1999 for the treatment of type 2 diabetes as an adjunct to diet and exercise. If approved, alogliptin/pioglitazone will be the first type 2 diabetes treatment option in the U.S. to include both a DPP-4 inhibitor and a thiazolidinedione (TZD) in a single tablet.

According to the International Diabetes Federation, a staggering 285 million individuals were living with diabetes worldwide in 2010.

"As recent figures indicate that diabetes continues to be a serious global health challenge, Takeda remains deeply committed to researching new and important therapeutic options for patients living with type 2 diabetes," said David Recker, M.D., senior vice president, clinical science, Takeda Global Research & Development Center. "Phase 3 studies have demonstrated that the combination of a
'/>"/>

SOURCE Takeda Global Research & Development Center, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Takeda Initiates Phase 3 Clinical Trial Program in the United States, Latin America, and Europe for Investigational Type 2 Diabetes Therapy TAK-875
2. Takeda Completes Acquisition and Names New CEO of Nycomed
3. Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program
4. Takeda Resubmits New Drug Applications in the U.S. for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
5. Takeda Responds to U.S. Food and Drug Administration Update to Safety Review of ACTOS (pioglitazone HCl)
6. Takeda to Acquire Nycomed
7. Amylin and Takeda Voluntarily Suspend Clinical Activities in Obesity Trial
8. Intra-Cellular Therapies and Takeda Enter into Worldwide Collaboration to Develop and Commercialize Compounds for Schizophrenia
9. Handa Pharmaceuticals Announces Submission of Its First-to-File ANDA for Takedas DEXILANT®
10. Takeda Submits New Drug Application in the U.S. for Azilsartan Medoxomil Plus Chlorthalidone, an Investigational Fixed-Dose Combination for the Treatment of Hypertension
11. Takeda Enters Into Global Strategic Partnerships With Covance and Quintiles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... , May 24, 2013  BD (Becton, Dickinson and ... technology company, announced today that it will present at the ... Thursday, May 30, 2013, at 10:40 a.m. (ET). ... from the BD corporate website at www.bd.com/investors and ... About BD BD is a ...
(Date:5/24/2013)... LOS ANGELES , May 24, 2013  An ... gathered on Saturday, May 18, in Santa ... findings on new lung-sparing therapies for MPM, a rare ... and commonly affects the pleura, the lining of the ... Heart, Lung and Blood Institute, the 3rd Annual International ...
(Date:5/24/2013)... , May 24, 2013  Auxilium Pharmaceuticals, Inc. ... management will participate in the Deutsche Bank Health Care ... Boston Waterfront Hotel.  Mr. Adrian Adams ... present an overview of the Company and its product ... 2013.   (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) ...
Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4
... Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced ... Health Care Conference on Thursday, May 27, 2010 at 2:30 ... , , ... on the "Investors & Media" section of the Company,s Web site, www.isispharm.com ...
... 20 Inverness Medical Innovations, Inc. (NYSE: IMA ... their health at home through the merger of rapid diagnostics and ... Global Life Sciences Conference being held June 8 through 11, ... . Ron Zwanziger, Chief Executive Officer, and Jon Russell , ...
Cached Medicine Technology:Isis Pharmaceuticals to Present at the 2010 Citi Investment Research Global Health Care Conference 2Inverness Medical Innovations to Attend the Jefferies 2010 Global Life Sciences Conference on June 8, 2010 2
(Date:5/25/2013)... York, NY (PRWEB) May 25, 2013 On ... that many people do not wish to discuss or plan ... in life. FuneralFinancials.com released a Must-Do List ... , 1. Funeral Financials recommends, “Creating a personal fact sheet.” ... used to organize financial information and personal data. It ...
(Date:5/25/2013)... New York,NY (PRWEB) May 25, 2013 ... SizeItUp officially declared the integration of the 2012 ... Lamborghini Aventador is the latest entrant in the list ... Designed intelligently, the vehicle is all set to thrill ... with vicious acceleration power and spectacular looks, the 2012 ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 Many orthodontists ... but wonder where exactly that cloud is. Most ... signing up with to provide their cloud service and ... that provide the service they're selling, they'd be wrong. ... center (a secure, redundant facility that houses servers ...
(Date:5/25/2013)... Plains, NJ (PRWEB) May 25, 2013 ... iPhone. The universal app version of Word Hunt ... app versions of Concentration, Edge Match, Flash 2, Sudoku and ... , The brain games’ gameplay and revolutionary lifetime brain fitness ... 4 inch displays. , “100 years of brain fitness measurement ...
(Date:5/25/2013)... Prairie Living at Chautauqua , ... American Red Cross Blood Drive from 1:30 to 5:30 ... is located at 955 Villa Ct. in Carbondale, Illinois, ... Medicaid, who need some help to maintain their independence.. ... Andrea Arview Frey, Director of Marketing for Prairie Living. ...
Breaking Medicine News(10 mins):Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2Health News:Acuity Games Apps Come to the iPhone 2Health News:Carbondale Affordable Assisted Living Community to Host Red Cross Blood Drive 2
... oil that is spilling into the Gulf of Mexico after a ... Mississippi, USA, on 22 April. In the black-and-white radar image ... the bottom right, while in the optical image it is seen ... and the Delta National Wildlife Refuge extends out into the Gulf. ...
... ... , ... View, CA (PRWEB) April 27, 2010 -- CureTogether ( http://www.curetogether.com ), an online social ... an online venue for parents with Autistic children to anonymously share and rate the ...
... ... including national, statewide and local leaders will gather at the FAME Renaissance Center to ... by First Lady Michelle Obama to fight childhood obesity and raise healthier children across ... , ...
... Angeles (April 26, 2010) Los Angeles Biomedical Research ... study the safety of a gel designed to reduce ... for Microbicides (IPM), a nonprofit global initiative to develop ... for International Development (USAID), the Institute announced today. ...
... CORVALLIS, Ore. Despite living in an age of iPads ... adults of the early 1900s than the baby boom generation: ... are making lower wages. Indeed, a new study points ... in common with his or her grandfather or great-grandfather than ...
... ... Before firing up the grill for the first time this year, take a few minutes with ... menu ideas at the Taste of Spring April 30 through May 2 in all clubs nationwide. ... F(PRWEB) April 27, 2010 -- ...
Cached Medicine News:Health News:CureTogether Announces Online Autism Treatment Study 2Health News:MEDIA ADVISORY: Let's Move L.A. Inaugural Event and Launch Party. April 28th, 2010. 11am - 2pm. 2Health News:MEDIA ADVISORY: Let's Move L.A. Inaugural Event and Launch Party. April 28th, 2010. 11am - 2pm. 3Health News:LA BioMed awarded research grant to study HIV prevention gel 2Health News:Lower wages, lack of job opportunities means more Americans delaying 'adulthood' 2Health News:Lower wages, lack of job opportunities means more Americans delaying 'adulthood' 3Health News:Lower wages, lack of job opportunities means more Americans delaying 'adulthood' 4Health News:Grill it up! Give Spring some Sizzle with Sam's Club 2
... Combines BchiVac V-500, water-cooled secondary condenser ... housing Model V-500 is a powerful PTFE ... vacuum applications. Applications Ideally ... rotary evaporators Laboratory vacuum source ...
... water-cooled secondary condenser to trap residual solvent ... membrane vacuum pump designed to handle most ... suited for use with up to two ... for instruments including vacuum ovens, concentrators, gel ...
... The Universal Vacuum System UVS400A is a ... The UVS400A combines a refrigerated vapor trap ... a single integrated unit. The easy-to-use, wide-mouth ... solvent into single jar for easy disposal. ...
Universal vacuum pump (capacity 34 L/min, 8 mbar vacuum abs.)...
Medicine Products: